2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2010 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2019 | 0 | 2.701.874 | 261.500 | 1 | ||
2016 | 0 | 8.553.750 | 485.000 | 1 | ||
2012 | 0 | 5.818.937 | 646.549 | 1 | ||
2011 | 0 | 29.980.670 | 202.800 | 1 | ||
2010 | 0 | 11.999.998 | 198.000 | 1 |
Total number of partners: 109
Partner loyalty:
Frequent Partner: (> 2 projects): 23
Rare Partner: 86
Frequent / Rare Partner Ratio: 0.27
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2019-01-01 | Novel vaccine vectors to resist pathogen challenge | VacPath | participant | 2.701.874 | 8 |
2016-04-01 | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 | VSV-EBOPLUS | participant | 8.553.750 | 11 |
2012-10-01 | Microbicide Optimization Through Innovative Formulation for Vaginal and Rectal Delivery | MOTIF | participant | 5.818.937 | 9 |
2011-10-01 | Advanced Immunization Technologies | ADITEC | participant | 29.980.670 | 52 |
2010-01-01 | Combined Highly Active Anti-retroviral Microbicides | CHAARM | participant | 11.999.998 | 34 |